NDC 66220-315
VIBATIV
Telavancin Hydrochloride
VIBATIV is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cumberland Pharmaceuticals Inc.. The primary component is Telavancin Hydrochloride.
| Product ID | 66220-315_ed26baa1-fb7b-485e-b53f-74694de6c086 |
| NDC | 66220-315 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VIBATIV |
| Generic Name | Telavancin Hydrochloride |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022110 |
| Labeler Name | Cumberland Pharmaceuticals Inc. |
| Substance Name | TELAVANCIN HYDROCHLORIDE |
| Active Ingredient Strength | 15 mg/mg |
| Pharm Classes | Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [EXT] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 66220-315-11
1 VIAL in 1 CARTON (66220-315-11) > 15 mg in 1 VIAL
| Marketing Start Date | 2021-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "VIBATIV" or generic name "Telavancin Hydrochloride"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52118-001 | Vibativ | telavancin hydrochloride |
| 52118-002 | Vibativ | telavancin hydrochloride |
| 62847-001 | Vibativ | telavancin hydrochloride |
| 62847-002 | Vibativ | telavancin hydrochloride |
| 66220-315 | VIBATIV | telavancin hydrochloride |
Trademark Results [VIBATIV]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VIBATIV 79035545 3939879 Live/Registered |
Cumberland Pharmaceuticals Inc. 2007-01-22 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.